Literature DB >> 23229913

Sentinel lymph node biopsy in early-stage breast cancer patients: improved survival through better staging?

Pamela Meiers1, Tulin Cil, Ulrich Guller, Markus Zuber.   

Abstract

PURPOSE: The objective of this review is to summarize the evidence demonstrating that the sentinel lymph node (SLN) procedure is not only associated with significantly less morbidity compared to the axillary dissection, but may also result in better staging and improved patient outcomes.
METHODS: A search of MedLine and PubMed articles using the terms "sentinel lymph node biopsy", "breast cancer", "staging", "morbidity", "survival", and "outcomes" was conducted.
RESULTS: Breast cancer staging includes axillary evaluation as an integral component. Over the past two decades, sentinel lymph node biopsy has evolved as a technique that has an improved morbidity over traditional axillary dissection. The sentinel node(s) undergo a more intensive pathologic examination than traditional axillary contents. In the node-negative group of patients, this may have led to stage migration and potentially improved disease-free and overall survival.
CONCLUSION: The SLN procedure is not only associated with significantly less morbidity compared to the axillary lymph node dissection, it may also result in more accurate staging, better axillary tumor control and improved survival.

Entities:  

Mesh:

Year:  2012        PMID: 23229913     DOI: 10.1007/s00423-012-1037-2

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  23 in total

1.  Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.

Authors:  K Dowlatshahi; M Fan; K J Bloom; D J Spitz; S Patel; H C Snider
Journal:  Cancer       Date:  1999-09-15       Impact factor: 6.860

2.  Survival analysis following sentinel lymph node biopsy: a validation trial demonstrating its accuracy in staging early breast cancer.

Authors:  John T Carlo; Michael D Grant; Sally M Knox; Ronald C Jones; Cody S Hamilton; Sheryl A Livingston; Joseph A Kuhn
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

Review 3.  Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

Authors:  P L Fitzgibbons; D L Page; D Weaver; A D Thor; D C Allred; G M Clark; S G Ruby; F O'Malley; J F Simpson; J L Connolly; D F Hayes; S B Edge; A Lichter; S J Schnitt
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

4.  Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.

Authors:  Kimberly A Vanderveen; Philip D Schneider; Vijay P Khatri; James E Goodnight; Richard J Bold
Journal:  Ann Surg Oncol       Date:  2006-09-29       Impact factor: 5.344

5.  Predictors of recurrence in stage I (T1N0M0) breast carcinoma.

Authors:  P P Rosen; P E Saigo; D W Braun; E Weathers; A DePalo
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

6.  Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.

Authors:  Charles Cox; Laura White; Nathon Allred; Michael Meyers; Daniel Dickson; Elisabeth Dupont; Alan Cantor; Quan Ly; Sophie Dessureault; Jeff King; Santo Nicosia; Vesna Vrcel; Nils Diaz
Journal:  Ann Surg Oncol       Date:  2006-03-16       Impact factor: 5.344

7.  Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.

Authors:  I Langer; U Guller; S F Hsu-Schmitz; A Ladewig; C T Viehl; H Moch; E Wight; F Harder; D Oertli; M Zuber
Journal:  Eur J Surg Oncol       Date:  2008-11-28       Impact factor: 4.424

8.  Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

Authors:  Anthony Lucci; Linda Mackie McCall; Peter D Beitsch; Patrick W Whitworth; Douglas S Reintgen; Peter W Blumencranz; A Marilyn Leitch; Sukumal Saha; Kelly K Hunt; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2007-05-07       Impact factor: 44.544

9.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

10.  Micrometastases or isolated tumor cells and the outcome of breast cancer.

Authors:  Maaike de Boer; Carolien H M van Deurzen; Jos A A M van Dijck; George F Borm; Paul J van Diest; Eddy M M Adang; Johan W R Nortier; Emiel J T Rutgers; Caroline Seynaeve; Marian B E Menke-Pluymers; Peter Bult; Vivianne C G Tjan-Heijnen
Journal:  N Engl J Med       Date:  2009-08-13       Impact factor: 91.245

View more
  4 in total

1.  Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial.

Authors:  Benjamin Weixler; Andreas Rickenbacher; Dimitri Aristotle Raptis; Carsten T Viehl; Ulrich Guller; Jessica Rueff; Andreas Zettl; Markus Zuber
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

2.  Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.

Authors:  Qiufan Zheng; Hanjia Luo; Wen Xia; Qianyi Lu; Kuikui Jiang; Ruoxi Hong; Fei Xu; Shusen Wang
Journal:  Breast Cancer Res Treat       Date:  2022-10-07       Impact factor: 4.624

3.  Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?

Authors:  Ann Smeets; Emi Yoshihara; Annouschka Laenen; Anneleen Reynders; Julie Soens; Hans Wildiers; Robert Paridaens; Chantal Van Ongeval; Giuseppe Floris; Patrick Neven; Marie-Rose Christiaens
Journal:  Springerplus       Date:  2013-06-23

4.  Complications and local relapse after intraoperative low-voltage X-ray radiotherapy in breast cancer.

Authors:  Ana Alicia Tejera Hernández; Víctor Manuel Vega Benítez; Juan Carlos Rocca Cardenas; Neith Ortega Pérez; Nieves Rodriguez Ibarria; Juan Carlos Díaz Chico; Juan José García-Granados Alayón; Pedro Pérez Correa; Juan Ramón Hernández Hernández
Journal:  Ann Surg Treat Res       Date:  2020-05-28       Impact factor: 1.766

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.